Filtered By:
Procedure: Hemodialysis

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 19524 results found since Jan 2013.

Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults
CONCLUSIONS: Given the low-certainty evidence, we are uncertain whether intermittent locking with heparin results in fewer central venous catheter occlusions than intermittent locking with normal saline in adults. Low-certainty evidence suggests that heparin may have little or no effect on catheter patency duration. Although we found no evidence of differences in safety (CVC-related bloodstream infections, mortality, or haemorrhage), the combined studies were not powered to detect rare adverse events such as heparin-induced thrombocytopaenia. Further research conducted over longer periods would reduce the current uncertain...
Source: Cochrane Database of Systematic Reviews - July 18, 2022 Category: General Medicine Authors: Eduardo L ópez-Briz Vicente Ruiz Garcia Juan B Cabello Sylvia Bort-Mart í Rafael Carbonell Sanchis Source Type: research

Alteplase for the treatment of catheter occlusion in pediatric patients.
CONCLUSIONS: Alteplase appears to show efficacy for treatment of thrombus-related venous catheter occlusion in pediatric patients; however, data regarding its use in occluded dialysis catheters are limited. PMID: 23463740 [PubMed - in process]
Source: The Annals of Pharmacotherapy - March 1, 2013 Category: Drugs & Pharmacology Authors: Anderson DM, Pesaturo KA, Casavant J, Ramsey EZ Tags: Ann Pharmacother Source Type: research

Treatment for peritoneal dialysis-associated peritonitis.
CONCLUSIONS: Many of the studies evaluating treatment of PD-related peritonitis are small, out-dated, of poor quality, and had inconsistent definitions and dosing regimens. IP administration of antibiotics was superior to IV administration for treating PD-associated peritonitis and glycopeptides appear optimal for complete cure of peritonitis, although evidence for this finding was assessed as low quality. PD catheter removal may be the best treatment for relapsing or persistent peritonitis.Evidence was insufficient to identify the optimal agent, route or duration of antibiotics to treat peritonitis. No specific antibiotic...
Source: Cochrane Database of Systematic Reviews - May 3, 2014 Category: Journals (General) Authors: Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GF Tags: Cochrane Database Syst Rev Source Type: research

HMG CoA reductase inhibitors (statins) for dialysis patients.
CONCLUSIONS: Statins have little or no beneficial effects on mortality or cardiovascular events and uncertain adverse effects in adults treated with dialysis despite clinically relevant reductions in serum cholesterol levels. PMID: 24022428 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - September 11, 2013 Category: Journals (General) Authors: Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF Tags: Cochrane Database Syst Rev Source Type: research

Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
CONCLUSIONS: Longer-acting ESA (darbepoetin and CERA) administered at one to four week intervals are non-inferior to rHuEPO given one to three times/week in terms of achieving haemoglobin targets without any significant differences in adverse events in haemodialysis patients. Additional RCTs are required to evaluate different frequencies of ESA in peritoneal and paediatric dialysis patients and to compare different longer-acting ESA (such as darbepoetin compared with CERA). PMID: 24872328 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - June 3, 2014 Category: Journals (General) Authors: Hahn D, Cody JD, Hodson EM Tags: Cochrane Database Syst Rev Source Type: research

Continuous renal replacement therapy (CRRT) for rhabdomyolysis.
CONCLUSIONS: Although CRRT may provide some benefits for people with rhabdomyolysis, the poor methodological quality of the included studies and lack of data relating to clinically important outcomes limited our findings about the effectiveness of CRRT for people with rhabdomyolysis.There was insufficient evidence to discern any likely benefits of CRRT over conventional therapy for people with rhabdomyolysis and prevention of rhabdomyolysis-induced AKI. PMID: 24929959 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - June 15, 2014 Category: Journals (General) Authors: Zeng X, Zhang L, Wu T, Fu P Tags: Cochrane Database Syst Rev Source Type: research

Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
CONCLUSIONS: Although Astragalus as an adjunctive treatment to conventional therapies was found to offer some promising effects in reducing proteinuria and increasing haemoglobin and serum albumin, suboptimal methodological quality and poor reporting meant that definitive conclusions could not be made based on available evidence. PMID: 25335553 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - October 22, 2014 Category: Journals (General) Authors: Zhang HW, Lin ZX, Xu C, Leung C, Chan LS Tags: Cochrane Database Syst Rev Source Type: research

Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
CONCLUSIONS: Convective dialysis may reduce cardiovascular but not all-cause mortality and effects on nonfatal cardiovascular events and hospitalisation are inconclusive. However, any treatment benefits of convective dialysis on all patient outcomes including cardiovascular death are unreliable due to limitations in study methods and reporting. Future studies which assess treatment effects of convection dose on patient outcomes including mortality and cardiovascular events would be informative. PMID: 25993563 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - May 20, 2015 Category: Journals (General) Authors: Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF Tags: Cochrane Database Syst Rev Source Type: research

Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
CONCLUSIONS: There was limited low quality evidence to indicate that dietary interventions (calcium-enriched bread or low phosphorus/protein intake) may positively affect CKD-MBD by increasing serum calcium, decreasing serum phosphorus, the calcium × phosphate product and FGF-23. Large and well-designed RCTs are needed to evaluate the effects of various interventions for people with CKD-MBD. PMID: 26376110 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - September 16, 2015 Category: Journals (General) Authors: Liu Z, Su G, Guo X, Wu Y, Liu X, Zou C, Zhang L, Yang Q, Xu Y, Ma W Tags: Cochrane Database Syst Rev Source Type: research

Preoperative vascular access evaluation for haemodialysis patients.
CONCLUSIONS: Based on four small studies, preoperative vessel imaging did not improve fistula outcomes compared with standard care. Adequately powered prospective studies are required to fully answer this question. PMID: 26418347 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - September 30, 2015 Category: Journals (General) Authors: Kosa SD, Al-Jaishi AA, Moist L, Lok CE Tags: Cochrane Database Syst Rev Source Type: research

Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.
CONCLUSIONS: We found no evidence to assess the benefits and harms of early versus delayed EPO for the anaemia of ESKD. PMID: 26671531 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - December 16, 2015 Category: Journals (General) Authors: Coronado Daza J, Martí-Carvajal AJ, Ariza García A, Rodelo Ceballos J, Yomayusa González N, Páez-Canro C, Loza Munárriz C, Urrútia G Tags: Cochrane Database Syst Rev Source Type: research

Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
CONCLUSIONS: The relative net benefit of anticoagulant therapies for prevention of catheter malfunction remains uncertain. Multiple agents appear to reduce catheter-related bacteraemia although the lack of clear assessment of harms and the limitations of study quality mean these results should be interpreted with caution. Methodological approaches can be used to avoid methods of reporting unduly affecting on the results of meta-analyses incorporating studies employed mixed reporting methods. Further high quality randomised studies, including safety outcomes, are needed. PMID: 27039404 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - April 3, 2016 Category: Journals (General) Authors: Wang Y, Ivany JN, Perkovic V, Gallagher MP, Woodward M, Jardine MJ Tags: Cochrane Database Syst Rev Source Type: research

In search for a biochemical marker of overhydration in hemodialysis: the "magic bullet" yet to be found.
Authors: Stompór T, Winiarska A PMID: 26266684 [PubMed - in process]
Source: Polskie Archiwum Medycyny Wewnetrznej - August 15, 2015 Category: Internal Medicine Tags: Pol Arch Med Wewn Source Type: research

Obesity and Mortality in End-Stage Renal Disease. Is It Time to Reverse the “Reverse Epidemiology”—at Least in Peritoneal Dialysis?
With the rising incidence of chronic kidney disease, there has been a steady growth of the hemodialysis (HD) and peritoneal dialysis (PD) population. Prevalence of obesity has also been on the rise. It has been proposed by some that obesity helps with survival in HD and possibly in PD patients —a concept called “Reverse Epidemiology.” Here, we attempt to explore this phenomenon in the HD and PD populations and see specifically if it is time to reverse this concept. A MEDLINE search was performed using search terms: obesity, body mass index, end-stage renal disease, HD, PD, renal dia lysis, mortality, survival, and reverse epidemiology.
Source: Journal of Renal Nutrition - November 15, 2018 Category: Urology & Nephrology Authors: Talha H. Imam, Karen J. Coleman Tags: Review Article Source Type: research